Navigating Non-interventional Post-authorization Studies in East Asia: Regulatory Challenges, Opportunities, and Future Directions.
Saved in:
| Title: | Navigating Non-interventional Post-authorization Studies in East Asia: Regulatory Challenges, Opportunities, and Future Directions. |
|---|---|
| Authors: | Peters J; Gilead Sciences Inc., Foster City, CA, USA. jami.peters5@gilead.com., Ali AK; BeOne Medicines Ltd., San Carlos, CA, USA., Moitinho de Almeida M; GSK, Wavre, Belgium., Asao K; Kappa Medical K.K., Tokyo, Japan., Hammad TA; Takeda Development Center Americas, Inc., Cambridge, MA, USA., He X; IQVIA, Shanghai, China., Michel A; Bayer Consumer Care AG, Basel, Switzerland., Rubino A; Gilead Sciences Europe Ltd, Uxbridge, UK., Sawada S; Nippon Boehringer Ingelheim Co., Ltd., Tokyo, Japan., Sobel RE; Regeneron Pharmaceuticals, Tarrytown, NY, USA., de Vogel S; Astellas Pharma Europe B.V., Leiden, The Netherlands. |
| Source: | Drug safety [Drug Saf] 2026 Mar; Vol. 49 (3), pp. 263-271. Date of Electronic Publication: 2025 Oct 17. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1179-1942 |
|---|---|
| DOI: | 10.1007/s40264-025-01621-x |
